Search Results | DrugBank Online

REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).

Investigational

VSF-173 is an oral small molecule. It is an oral compound that has demonstrated effects on animal sleep/wake patterns and gene expression patterns suggestive of a stimulant effect. It is developed for the treatment of excessive sleepiness. Study shows that VSF-173 possesses a novel mechanism to address disorders of excessive...

Investigational

Matched Description: … It is an oral compound that has demonstrated effects on animal sleep/wake patterns and gene expression …

Advanced Filter

Filter by Group

Filter by Market Availability

Immucillin-G

1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE

(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one

CRA-9334

Doramapimod

(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine

MRX-I

4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL

1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA

(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one

Lufenuron

T-62

REP8839

VSF-173

Dipipanone

2,3,4,5,6-Pentafluorobenzyl Alcohol

Iodobenzene

ES-936

1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane

S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea

4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole

4-Fluorophenethyl Alcohol

1,3,5-trichlorobenzene

N-(Chlorophenyl)-N'-hydroxyguanidine

(R)-4-Nitrostyrene oxide